STOCKHOLDERS’ EQUITY

6 Months Ended

Jun. 30, 2025

Equity [Abstract]

STOCKHOLDERS’ EQUITY

NOTE 8 – STOCKHOLDERS’ EQUITY

Stock Compensation

The Company offers incentive stock option grants to directors and key employees. Options vest in tranches and typically expire five (5) years from the date of grant. For the six (6) months ended June 30, 2025, and 2024, the Company recorded stock option expense of $484,014 and $446,746, respectively. For the three (3) months ended June 30, 2025, and 2024, the Company recorded stock option expense of $244,677 and $222,677, respectively. The option expense not taken as of June 30, 2025, is $3,050,455, with a weighted average term of 2.76 years.

The following table represents stock option activity as of and for the six (6) months ended June 30, 2025:

	Number of			Weighted Average		Weighted Average		Aggregate
	Shares			Exercise Price		Remaining Life		Intrinsic Value
Options Outstanding – December 31, 2024		5,650,000		$	0.78		3.80	$	—
Granted		—			—		—		—
Exercised		(75,000	)		0.15		—		—
Forfeited		(75,000	)		—		—		—
Options Outstanding – June 30, 2025		5,500,000		$	0.40		1.30	$	—
Exercisable and Vested, June 30, 2025		2,801,664		$	0.52		1.49	$	—

The aggregate intrinsic value for options outstanding as of June 30, 2025, is not calculated because the closing stock price on June 30, 2025, is less than the weighted average exercise price of outstanding options on that date.